These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 33458427)

  • 41.
    Udovicich C; Perera M; Hofman MS; Siva S; Del Rio A; Murphy DG; Lawrentschuk N
    Prostate Int; 2017 Dec; 5(4):125-129. PubMed ID: 29188197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of
    Belli ML; Sarnelli A; Mezzenga E; Cesarini F; Caroli P; Di Iorio V; Strigari L; Cremonesi M; Romeo A; Nicolini S; Matteucci F; Severi S; Paganelli G
    Front Oncol; 2020; 10():531660. PubMed ID: 33251129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [
    Tönnesmann R; Meyer PT; Eder M; Baranski AC
    Pharmaceuticals (Basel); 2019 Jan; 12(1):. PubMed ID: 30678341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of hybrid
    Janssen JC; Meißner S; Woythal N; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
    Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
    van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
    BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer.
    Kabasakal L; AbuQbeitah M; Aygün A; Yeyin N; Ocak M; Demirci E; Toklu T
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1976-83. PubMed ID: 26227531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).
    Ahn T; Roberts MJ; Abduljabar A; Joshi A; Perera M; Rhee H; Wood S; Vela I
    Mol Imaging Biol; 2019 Oct; 21(5):799-807. PubMed ID: 30617728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer.
    Tateishi U
    Jpn J Clin Oncol; 2020 Apr; 50(4):349-356. PubMed ID: 32147685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
    Touijer KA; Michaud L; Alvarez HAV; Gopalan A; Kossatz S; Gonen M; Beattie B; Sandler I; Lyaschenko S; Eastham JA; Scardino PT; Hricak H; Weber WA
    Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.
    Schmidt-Hegemann NS; Fendler WP; Buchner A; Stief C; Rogowski P; Niyazi M; Eze C; Li M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2017 Nov; 12(1):176. PubMed ID: 29126446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of new salivary gland - A substantial histological analysis.
    N B P; Ravi KS; Durgapal P
    Radiother Oncol; 2021 Aug; 161():92-94. PubMed ID: 34119589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging science and development in modern high-precision radiotherapy.
    Thorwarth D; Muren L
    Phys Imaging Radiat Oncol; 2019 Oct; 12():63-66. PubMed ID: 33458297
    [No Abstract]   [Full Text] [Related]  

  • 55. PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy.
    Mohan V; Vogel WV; Valk GD; de Boer JP; Lam MGEH; de Keizer B
    Mol Imaging; 2020; 19():1536012120934992. PubMed ID: 32619138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.
    Klein Nulent TJW; Valstar MH; de Keizer B; Willems SM; Smit LA; Al-Mamgani A; Smeele LE; van Es RJJ; de Bree R; Vogel WV
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):478-486. PubMed ID: 29523427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose response modelling of secretory cell loss in salivary glands using PSMA PET.
    Mohan V; Bruin NM; Steenbakkers RJHM; Noordzij W; Terhaard CHJ; de Keizer B; Al-Mamgani A; van de Kamer JB; Sonke JJ; Vogel WV
    Radiother Oncol; 2022 Dec; 177():164-171. PubMed ID: 36368471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
    Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
    BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate-specific membrane antigen positron emission tomography/computed tomography as a potential tool to assess and guide salivary gland irradiation.
    Valstar MH; Owers EC; Al-Mamgani A; Smeele LE; van de Kamer JB; Sonke JJ; Vogel WV
    Phys Imaging Radiat Oncol; 2019 Jan; 9():65-68. PubMed ID: 33458427
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.